Point72 Hong Kong LTD Praxis Precision Medicines, Inc. Transaction History

Point72 Hong Kong LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$2.5 - $4.77 $12,755 - $24,336	5,102 New	5,102 $12,000
Q2 2022 Aug 15, 2022	SELL	$1.75 - $11.34 $2,247 - $14,560	-1,284 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$10.21 - $20.29 $2,869 - $5,701	-281 Reduced 17.96%	1,284 $13,000
Q4 2021 Feb 14, 2022	BUY	$16.76 - $22.99 $26,229 - $35,979	1,565 New	1,565 $31,000
Q2 2021 Aug 16, 2021	SELL	$18.28 - $33.05 $6,507 - $11,765	-356 Closed	0 $0

Q1 2021 May 17, 2021	BUY	$29.34 - $60.2 $10,445 - $21,431	356 New	356 $12,000

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $1.84B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.